Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - ONA

Links shared publicly online about this topic.

  • 530
    total visits

Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - ONA

oncologynurseadvisor.com

pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).

View full resource at oncologynurseadvisor.com

Tags: Edema, Diabetes, Phase 3 Clinical Trial

  • Share

Most Recently Shared on February 4, 2011 at 6:36 pm By:

ONAcom OncologyNurseAdvisor

Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) http://goo.gl/fb/ZLLpF

1 year ago...

Phase 3 Study of Iluvien for Diabetic Macular Edema - MPR

empr.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 4:06 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 Study of Iluvien for Diabetic Macular Edema: pSivida Corp. announced new data from its Phase 3... http://bit.ly/iisxtm

12 months ago...

pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN in Diabetic Macular Edema - Drugs.com MedNews

drugs.com — “May 3, 2011 - pSivida Corp. (NASDAQ PSDV)(ASX PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases,View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 3:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN in Diabetic Macular Edema: WA... http://bit.ly/m4Qvh9 #drug

12 months ago...

Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - MPR

empr.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on February 4, 2011 at 6:25 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME): pSivida Corporation anno... http://bit.ly/gDuoFl

1 year ago...

Advertisement